Evidence map›Paper›PMID 33380827›Full record

ArticleCancer management and research2020

TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect.

Yutong Xing, Peng Luo, Rui Hu, Duanduan Wang, Gang Zhou, Jie Jiang

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Calcium Phosphate Nanoparticle Delivery of siInternational journal of nanomedicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yutong Xing *Department of Cardiothoracic Surgery, The Fifth Hospital of Xiamen, Xiamen, People's Republic of China.
Peng Luo *Department of Cardiothoracic Surgery, The First Affiliated Hospital of Jiamusi University, Jiamusi, People's Republic of China.
Rui HuDepartment of Cardiothoracic Surgery, The Fifth Hospital of Xiamen, Xiamen, People's Republic of China.
Duanduan WangDepartment of Cardiothoracic Surgery, The Fifth Hospital of Xiamen, Xiamen, People's Republic of China.
Gang ZhouDepartment of Cardiothoracic Surgery, The First Affiliated Hospital of Jiamusi University, Jiamusi, People's Republic of China.
Jie JiangDepartment of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, People's Republic of China.
First Affiliated Hospital of Jiamusi University · CNFifth Hospital of Shijiazhuang · CNFirst Affiliated Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pseudokinase Tribbles 3 (TRIB3) is involved in many cellular processes and various cancers. In recent years, the importance of metabolic transformation in the maintenance of malignant tumors has become increasingly prominent. Abnormal metabolism of cancer cells is considered a hallmark of cancer. However, the exact role and molecular mechanism of TRIB3 in lung adenocarcinoma (LUAD) cell reprogramming is largely unknown.

methodsThe oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) of cells were examined with a Seahorse XF Extracellular Flux Analyzer. In vitro and in vivo RT-qPCR, Western blotting, and functional assays were performed to explore the functional roles of TRIB3 in LUAD.

resultsIn the present study, we demonstrated that TRIB3 is remarkably upregulated in LUAD cell lines as well as tissues. TRIB3 knockdown significantly inhibited LUAD cell growth and suppressed LUAD cell invasion, while TRIB3 overexpression conferred the opposite effects. Moreover, silencing TRIB3 suppressed the tumorigenesis and metastatic ability of LUAD cells. Mechanistically, we demonstrated that silencing TRIB3 significantly impaired aerobic glycolysis ability in LUAD cells. Furthermore, our data indicated that TRIB3 knockdown decreased hypoxia-inducible factor (HIF)1α levels and targeted the glycolytic genes regulated by HIF1α.

conclusionTogether, our findings revealed a previously unappreciated function of TRIB3 in cancer cell metabolism and tumor progression, illustrating that TRIB3 could be considered a valuable therapeutic target for LUAD patients.

Indexed as

aerobic glycolysisHIF1αLUADTRIB3

Identifiers

PMID33380827
PMCPMC7767749
OpenAlexW3116964114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.